Latest News about SRPT
Recent news which mentions SRPT
   Earnings Scheduled For February 28, 2023
   
  
  
  February 28, 2023
  From Benzinga
 
   3 Gene Editing Stocks With the Best Long-Term Potential
   
  
  
  January 25, 2023
  From InvestorPlace
 
   7 Biotech Stocks That Will Make You Rich in 10 Years
   
  
  
  January 18, 2023
  From InvestorPlace
 
   2 Under-the-Radar Biotech Stocks to Buy in 2023
   
  
  
  January 06, 2023
  From Motley Fool
 
   2 Top Healthcare Stocks to Buy for the Long Haul
   
  
  
  December 09, 2022
  From Motley Fool
 
   Sarepta Therapeutics (SRPT) Q3 2022 Earnings Call Transcript
   
  November 03, 2022
  Tickers 
   SRPT
  
  
  From Motley Fool
 
   Earnings Scheduled For November 2, 2022
   
  
  
  November 02, 2022
  From Benzinga
 
   3 Unstoppable Stocks That Could Double in 5 Years
   
  
  
  October 29, 2022
  From Motley Fool
 
   2 Under-the-Radar Biotech Stocks to Buy in 2022
   
  
  
  October 19, 2022
  From Motley Fool
 From Benzinga
 
   PepGen's Duchenne Candidate Has Potential For Greater Exon Skipping Capabilities At Lower Doses Versus Sarepta's Candidate, Says Analyst
   
  
  
  September 28, 2022
  From Benzinga
 
   $6 Million Bet On Sarepta Therapeutics? 3 Stocks Insiders Are Buying
   
  
  
  September 16, 2022
  From Benzinga
 
   A Biotech's Stock Just Hit Year High. This Analyst Expects It To Jump Another 16%
   
  September 08, 2022
  Tickers 
   SRPT
  
  
  From Benzinga
 
   FDA Lifts Clinical Hold On Sarepta's Dose-Expansion Part Of Duchenne Trial
   
  September 06, 2022
  Tickers 
   SRPT
  
  
  From Benzinga
 
   3 Biotech Stocks You Can Buy and Hold for the Next Decade
   
  
  
  August 29, 2022
  From Motley Fool
 
   Sarepta In-Licenses Next-Gen AAV Tech Covering Five Indications
   
  August 08, 2022
  Tickers 
   SRPT
  
  
  From Benzinga
 
   Sarepta Therapeutics (SRPT) Q2 2022 Earnings Call Transcript
   
  August 02, 2022
  Tickers 
   SRPT
  
  
  From Motley Fool
 
   Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
   
  
  
  August 02, 2022
  From Benzinga
 
   Earnings Scheduled For August 2, 2022
   
  
  
  August 02, 2022
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
